Bausch Health Co. Inc. (BHC) Misses Q1 EPS by 86c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
Bausch Health Companies (BHC) PT Lowered to $10 at RBC Capital
May 3, 2024 6:36 AM EDTRBC Capital analyst Doug Miehm lowered the price target on Bausch Health Companies (NYSE: BHC) to $10.00 (from $11.00) while maintaining a Sector Perform rating.
The analyst comments "Between Q1 EBITDA that was weaker than expected and little incremental visibility on the BLCO separation... More
